Ovarian carcinomas with genetic and epigenetic BRCA1 loss have distinct molecular abnormalities

被引:0
|
作者
Joshua Z Press
Alessandro De Luca
Niki Boyd
Sean Young
Armelle Troussard
Yolanda Ridge
Pardeep Kaurah
Steve E Kalloger
Katherine A Blood
Margaret Smith
Paul T Spellman
Yuker Wang
Dianne M Miller
Doug Horsman
Malek Faham
C Blake Gilks
Joe Gray
David G Huntsman
机构
[1] University of British Columbia,Department of Obstetrics and Gynecology
[2] University of British Columbia,Department of Pathology and Laboratory Medicine
[3] Hereditary Cancer Program,Genetic Pathology Evaluation Centre of the Prostate Centre
[4] British Columbia Cancer Agency,Life Sciences Division, Lawrence Berkeley National Laboratory
[5] Vancouver General Hospital,Department of Gynecologic Oncology
[6] Molecular Genetics,undefined
[7] The Royal Melbourne Hospital,undefined
[8] University of California,undefined
[9] Affymetrix Inc,undefined
[10] University of British Columbia,undefined
来源
BMC Cancer | / 8卷
关键词
Ovarian Cancer; Ovarian Carcinoma; BRCA1 Mutation; Promoter Hypermethylation; BRCA1 Promoter;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [41] Hereditary breast and ovarian cancer in Asia:: Genetic epidemiology of BRCA1 and BRCA2
    Liede, A
    Narod, SA
    HUMAN MUTATION, 2002, 20 (06) : 413 - 424
  • [42] BRCA1 and BRCA2 Genetic Testing in Breast and/or Ovarian Cancer Families in Iran
    Keshavarzi, Fatemeh
    Javadi, Gholam Reza
    Nafissi, Nahid
    Akbari, Mohammad Esmail
    Yassaee, Vahid Reza
    Farzad, Maryam Sharafi
    Zeinali, Sirous
    YAKHTEH, 2010, 12 (03): : 329 - 340
  • [44] Differential ovarian cancer survival in Ashkenazi BRCA1/BRCA1 carriers.
    Levy-Lahad, E
    Kaufman, B
    Eisenberg, S
    Gottfeld, O
    Beller, U
    Renbaum, P
    Lahad, A
    Catane, R
    AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 65 (04) : A135 - A135
  • [45] Loss of heterozygosity at BRCA1/2 loci in hereditary and sporadic ovarian cancers
    Brozek, I.
    Ochman, K.
    Debniak, J.
    Morzuch, L.
    Ratajska, M.
    Stepnowska, M.
    Stukan, M.
    Emerich, J.
    Limon, J.
    JOURNAL OF APPLIED GENETICS, 2009, 50 (04) : 379 - 384
  • [46] Epigenetic scars of Brca1 loss point toward breast cancer cell of origin
    Lewis, Steven M.
    dos Santos, Camila
    NATURE GENETICS, 2024, 56 (12) : 2594 - 2595
  • [47] Frequent loss of BRCA1 mRNA and protein expression in sporadic ovarian cancers
    Russell, PA
    Pharoah, PDP
    De Foy, K
    Ramus, SJ
    Symmonds, I
    Wilson, A
    Scott, I
    Ponder, BAJ
    Gayther, SA
    INTERNATIONAL JOURNAL OF CANCER, 2000, 87 (03) : 317 - 321
  • [48] BRCA1 mutation site may associate with nuclear DNA content in BRCA1-associated ovarian carcinomas.
    Aghmesheh, M
    Friedlander, M
    Russell, PJ
    Edwards, L
    Yang, JL
    Kconfab, K
    Nesland, JM
    Danielson, H
    Kaern, J
    Tucker, KM
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 459S - 459S
  • [49] Gain-of-function and loss-of-function TP53 mutations in ovarian carcinomas with andwithout concurrent BRCA1 or BRCA2 mutations
    Ghezelayagh, T.
    Pennington, K.
    Norquist, B. M.
    Harrell, M. I.
    Agnew, K. J.
    Radke, M. R.
    Collett, G.
    Lee, M. K.
    Swisher, E. M.
    GYNECOLOGIC ONCOLOGY, 2018, 149 : 64 - 64
  • [50] GENETIC SCREENING FOR BRCA1 MUTATIONS IN BREAST AND/OR OVARIAN-CANCER FAMILIES
    TARTAGLINI, E
    BADZIOCH, M
    ANDERSON, D
    SAUNDERS, GF
    AMERICAN JOURNAL OF HUMAN GENETICS, 1995, 57 (04) : 419 - 419